FI20001776L - Menetelmä farmaseuttisen koostumuksen valmistamiseksi - Google Patents

Menetelmä farmaseuttisen koostumuksen valmistamiseksi Download PDF

Info

Publication number: FI20001776L
Authority: FI; Finland
Prior art keywords: preparing; pharmaceutical composition; pharmaceutical; composition
Prior art date: 1992-06-05

Application number

FI20001776A

Other languages

English (en)

Swedish (sv)

Other versions

FI20001776A7 (fi

Inventor

Raymond Baker

Victor G Matassa

Kendal G Pitt

Leslie J Street

Alexander R Guiblin

Carole Olive

David E Storey

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-05

Filing date

2000-08-10

Publication date

2000-08-10

1992-06-05 Priority claimed from GB929211903A external-priority patent/GB9211903D0/en

1993-04-07 Priority claimed from GB939307306A external-priority patent/GB9307306D0/en

2000-08-10 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2000-08-10 Publication of FI20001776A7 publication Critical patent/FI20001776A7/fi

2000-08-10 Publication of FI20001776L publication Critical patent/FI20001776L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

FI20001776A 1992-06-05 2000-08-10 Menetelmä farmaseuttisen koostumuksen valmistamiseksi FI20001776L (fi)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB929211903A GB9211903D0 (en)	1992-06-05	1992-06-05	Pharmaceutical composition
GB939307306A GB9307306D0 (en)	1993-04-07	1993-04-07	Therapeutic agents
PCT/GB1993/001132 WO1993025547A1 (en)	1992-06-05	1993-05-28	The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy

Publications (2)

Publication Number	Publication Date
FI20001776A7 FI20001776A7 (fi)	2000-08-10
FI20001776L true FI20001776L (fi)	2000-08-10

Family

ID=26301005

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
FI945694A FI106201B (fi)	1992-06-05	1994-12-02	Menetelmä substituoidun triatsolin sulfaattisuolan valmistamiseksi
FI20001776A FI20001776L (fi)	1992-06-05	2000-08-10	Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI20001777A FI20001777A7 (fi)	1992-06-05	2000-08-10	Substituoidun triatsolin sulfaattisuola ja sen farmaseuttisia koostumuksia

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FI945694A FI106201B (fi)	1992-06-05	1994-12-02	Menetelmä substituoidun triatsolin sulfaattisuolan valmistamiseksi

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FI20001777A FI20001777A7 (fi)	1992-06-05	2000-08-10	Substituoidun triatsolin sulfaattisuola ja sen farmaseuttisia koostumuksia

Country Status (27)

Country	Link
US (1)	US5527817A (fi)
EP (1)	EP0573221B1 (fi)
JP (2)	JP2619197B2 (fi)
KR (1)	KR100286411B1 (fi)
CN (1)	CN1043532C (fi)
AT (1)	ATE165602T1 (fi)
AU (2)	AU659311B2 (fi)
BG (1)	BG61976B1 (fi)
CA (1)	CA2097208C (fi)
CZ (1)	CZ282060B6 (fi)
DE (1)	DE69318212T2 (fi)
DK (1)	DK0573221T3 (fi)
ES (1)	ES2116411T3 (fi)
FI (3)	FI106201B (fi)
HK (1)	HK1010050A1 (fi)
HU (1)	HUT71403A (fi)
IL (1)	IL105847A (fi)
LV (1)	LV12210B (fi)
MX (1)	MX9303373A (fi)
NO (1)	NO307420B1 (fi)
NZ (1)	NZ253210A (fi)
RO (1)	RO114326B1 (fi)
RU (1)	RU2130022C1 (fi)
SG (1)	SG50406A1 (fi)
SK (1)	SK279211B6 (fi)
UA (1)	UA27908C2 (fi)
WO (1)	WO1993025547A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ253210A (en) *	1992-06-05	1995-09-26	Merck Sharp & Dohme	The sulphate salt of 3-(dimethylaminoethyl)-5-(1,2,4-triazol -1-ylmethyl) indole and medicaments
ZA965837B (en) *	1995-07-11	1997-01-31	Merck & Co Inc	A triazolylmethyl-indole ethylamine bisulfate salt
AU6542896A (en) *	1995-07-11	1997-02-10	Merck & Co., Inc.	A triazolylmethyl-indole ethylamine bisulfate salt
US6349719B2 (en)	1997-02-24	2002-02-26	Aradigm Corporation	Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6192882B1 (en) *	1997-02-24	2001-02-27	Aradigm Corporation	Formulation and devices for monitoring the efficacy of the delivery of aerosols
JP2002528498A (ja) *	1998-11-02	2002-09-03	メルクエンドカムパニーインコーポレーテッド	片頭痛の治療方法及び医薬組成物
ES2623094T3 (es)	2001-08-15	2017-07-10	Pharmacia & Upjohn Company Llc	Procedimientos de preparación de cristales que incluyen una sal de ácido málico de N-[2-(dietilamino)etil]-5-[(5-fluoro-1,2-dihidro-2-oxo-3H-indol-3-iliden)metil]-2,4-dimetil-1H-pirrol-3-carboxamida
WO2006137083A1 (en) *	2005-06-20	2006-12-28	Natco Pharma Limited	Improved process for the preparation of rizatriptan benzoate
ES2270717B1 (es) *	2005-08-08	2008-03-01	Ragactives, S.L.	Procedimiento para la obtencion de derivados de triptamina.
US20090062550A1 (en) *	2005-11-14	2009-03-05	Matrix Laboratories Ltd	Process for the Large Scale Production of Rizatriptan Benzoate
US20100256208A1 (en) *	2007-06-04	2010-10-07	Gore Vinayak G	Novel process
BR112018015367A2 (pt)	2016-01-27	2018-12-18	Instar Tech A S	carreadores oromucosais de nanofibra para tratamento terapêutico
WO2024144413A1 (ru) *	2022-12-28	2024-07-04	Общество С Ограниченной Ответственностью "Ферринг Продакшн"	Жидкая фармацевтическая композиция для назального введения, содержащая ризатриптан

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU1528319A3 (ru) *	1985-07-23	1989-12-07	Глэксо Груп Лимитед (Фирма)	Способ получени производных имидазола или их физиологически приемлемых солей
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
ATE137501T1 (de) *	1989-07-03	1996-05-15	Yoshitomi Pharmaceutical	Benzazin-verbindungen und deren pharmazeutische verwendungen
US5075313A (en) *	1990-09-13	1991-12-24	Eli Lilly And Company	3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
GB9026998D0 (en) *	1990-12-12	1991-01-30	Glaxo Group Ltd	Medicaments
SK278998B6 (sk) *	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
NZ253210A (en) *	1992-06-05	1995-09-26	Merck Sharp & Dohme	The sulphate salt of 3-(dimethylaminoethyl)-5-(1,2,4-triazol -1-ylmethyl) indole and medicaments

1993
- 1993-05-28 NZ NZ253210A patent/NZ253210A/en unknown
- 1993-05-28 ES ES93304158T patent/ES2116411T3/es not_active Expired - Lifetime
- 1993-05-28 AT AT93304158T patent/ATE165602T1/de not_active IP Right Cessation
- 1993-05-28 CZ CZ943044A patent/CZ282060B6/cs not_active IP Right Cessation
- 1993-05-28 WO PCT/GB1993/001132 patent/WO1993025547A1/en not_active Ceased
- 1993-05-28 KR KR1019940704402A patent/KR100286411B1/ko not_active Expired - Fee Related
- 1993-05-28 AU AU39875/93A patent/AU659311B2/en not_active Ceased
- 1993-05-28 AU AU43372/93A patent/AU4337293A/en not_active Abandoned
- 1993-05-28 SK SK1479-94A patent/SK279211B6/sk unknown
- 1993-05-28 EP EP93304158A patent/EP0573221B1/en not_active Expired - Lifetime
- 1993-05-28 DE DE69318212T patent/DE69318212T2/de not_active Expired - Fee Related
- 1993-05-28 RU RU94046380/04A patent/RU2130022C1/ru not_active IP Right Cessation
- 1993-05-28 JP JP5127463A patent/JP2619197B2/ja not_active Expired - Fee Related
- 1993-05-28 HU HU9403478A patent/HUT71403A/hu unknown
- 1993-05-28 DK DK93304158T patent/DK0573221T3/da active
- 1993-05-28 SG SG1996000374A patent/SG50406A1/en unknown
- 1993-05-28 CA CA002097208A patent/CA2097208C/en not_active Expired - Fee Related
- 1993-05-28 UA UA94129126A patent/UA27908C2/uk unknown
- 1993-05-28 RO RO94-01910A patent/RO114326B1/ro unknown
- 1993-05-31 IL IL10584793A patent/IL105847A/en not_active IP Right Cessation
- 1993-06-04 MX MX9303373A patent/MX9303373A/es not_active IP Right Cessation
- 1993-06-05 CN CN93108728A patent/CN1043532C/zh not_active Expired - Fee Related
1994
- 1994-10-21 BG BG99132A patent/BG61976B1/bg unknown
- 1994-12-02 NO NO944656A patent/NO307420B1/no not_active IP Right Cessation
- 1994-12-02 FI FI945694A patent/FI106201B/fi active
- 1994-12-07 US US08/350,760 patent/US5527817A/en not_active Expired - Lifetime
1996
- 1996-08-30 JP JP8230809A patent/JP2972150B2/ja not_active Expired - Fee Related
1998
- 1998-09-05 HK HK98110478A patent/HK1010050A1/en not_active IP Right Cessation
- 1998-10-26 LV LVP-98-237A patent/LV12210B/en unknown
2000
- 2000-08-10 FI FI20001776A patent/FI20001776L/fi unknown
- 2000-08-10 FI FI20001777A patent/FI20001777A7/fi unknown

Also Published As

Publication number	Publication date
AU3987593A (en)	1993-12-09
CZ304494A3 (en)	1995-09-13
LV12210B (en)	1999-03-20
EP0573221A1 (en)	1993-12-08
WO1993025547A1 (en)	1993-12-23
LV12210A (lv)	1999-01-20
KR950701922A (ko)	1995-05-17
NO944656L (no)	1994-12-02
FI106201B (fi)	2000-12-15
DE69318212D1 (de)	1998-06-04
CA2097208C (en)	2005-02-08
EP0573221B1 (en)	1998-04-29
JPH09176155A (ja)	1997-07-08
HU9403478D0 (en)	1995-02-28
FI20001776A7 (fi)	2000-08-10
IL105847A (en)	1998-09-24
CZ282060B6 (cs)	1997-05-14
RO114326B1 (ro)	1999-03-30
NZ253210A (en)	1995-09-26
SG50406A1 (en)	1998-07-20
RU2130022C1 (ru)	1999-05-10
AU659311B2 (en)	1995-05-11
KR100286411B1 (ko)	2001-04-16
IL105847A0 (en)	1993-09-22
JP2972150B2 (ja)	1999-11-08
JP2619197B2 (ja)	1997-06-11
AU4337293A (en)	1994-01-04
JPH0641121A (ja)	1994-02-15
FI945694A0 (fi)	1994-12-02
RU94046380A (ru)	1996-12-10
BG61976B1 (bg)	1998-11-30
CN1043532C (zh)	1999-06-02
CN1089263A (zh)	1994-07-13
NO307420B1 (no)	2000-04-03
SK279211B6 (sk)	1998-08-05
HUT71403A (en)	1995-11-28
DK0573221T3 (da)	1998-10-07
CA2097208A1 (en)	1993-12-06
UA27908C2 (uk)	2000-10-16
SK147994A3 (en)	1995-07-11
MX9303373A (es)	1995-01-31
ATE165602T1 (de)	1998-05-15
BG99132A (bg)	1995-07-28
HK1010050A1 (en)	1999-06-11
FI945694L (fi)	1994-12-02
FI20001777L (fi)	2000-08-10
NO944656D0 (no)	1994-12-02
US5527817A (en)	1996-06-18
ES2116411T3 (es)	1998-07-16
DE69318212T2 (de)	1998-11-19
FI20001777A7 (fi)	2000-08-10

Publication	Publication Date	Title
FI914398A7 (fi)	1992-03-21	Menetelmä farmaseuttisen kokoonpanon valmistamiseksi
FI906249A7 (fi)	1991-06-22	Menetelmä farmaseuttisen seoksen valmistamiseksi
GB9227166D0 (en)	1993-02-24	A method for preparing pharmaceutical compositions
FI892640L (fi)	1989-12-02	Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI894342L (fi)	1990-03-17	Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI945465L (fi)	1994-11-21	Menetelmä hidastetusti vapauttavien lääkevalmisteiden valmistamiseksi
FI20000084L (fi)	2000-01-17	Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi
FI933357A7 (fi)	1993-08-19	Menetelmä benzamidien valmistamiseksi
FI20090384L (fi)	2009-10-21	Menetelmä modifioidun G-CSF-polypeptidin valmistamiseksi
GR1002184B (en)	1996-03-12	Method for preparating intravenous pharmaceutical compositions
FI885884L (fi)	1989-06-22	Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI945441L (fi)	1994-11-18	Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
FI945451L (fi)	1994-12-22	Makeutusaineina käytettäviä yhdisteitä sekä menetelmä niiden valmistamiseksi
FI962069L (fi)	1996-05-15	Menetelmä karpolaktaamin valmistamiseksi
FI921021A7 (fi)	1992-09-10	Menetelmä trans-Pt(IV)-yhdisteiden valmistamiseksi
FI891570L (fi)	1989-10-02	Menetelmä piroksikaamia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI940769A7 (fi)	1994-08-20	Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI941046A7 (fi)	1994-03-04	Farmaseuttinen menetelmä
FI20001776L (fi)	2000-08-10	Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI955800L (fi)	1995-12-01	Menetelmä aminoalkyyliganidiinien valmistamiseksi
FI943222L (fi)	1994-08-18	Uusia adenosiinijohdannaisia, menetelmä niiden valmistamiseksi sekä niitä sisältäviä lääkeyhdisteitä
FI912868A7 (fi)	1991-12-16	Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
FI913554L (fi)	1992-01-26	Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
FI923498A7 (fi)	1993-02-07	Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI935019L (fi)	1995-05-13	Menetelmä klodronaattivalmisteen valmistamiseksi